Children with sickle cell disease are at risk of cognitive deficits and somatic growth delays beginning in early childhood. We examined growth velocity from age 2 years (height and body mass index progression over time) and cognitive functioning in 46 children with sickle cell disease 4 to 8 years of age. Height-for-age velocity was not associated with cognitive outcomes. Higher body mass index velocity was associated with higher scores on global cognitive and visual-motor abilities but not processing resources or academic achievement. Body mass index progression over time may be a clinically useful indicator of neurocognitive risk in sickle cell disease, as it may reflect multiple sickle cell disease–related risk factors.
Aarnoudse-MoensCSWeisglas-KuperusNvan GoudoeverJB. (2009) Meta-analysis of neurobehavioral outcomes in very preterm and/or very low birth weight children. Pediatrics124(2): 717–728.
2.
AdamsRJ (2005) TCD in sickle cell disease: An important and useful test. Pediatric Radiology35(3): 229–234.
3.
AkohoueSAShankarSMilneGL. (2007) Energy expenditure, inflammation, and oxidative stress in steady-state adolescents with sickle cell anemia. Pediatric Research61(2): 233–238.
4.
Al-SaqladiAWCipolottiRFijnvandraatK. (2008) Growth and nutritional status of children with homozygous sickle cell disease. Annals of Tropical Paediatrics28(3): 165–189.
5.
BardenEMKawchakDAOhene-FrempongK. (2002) Body composition in children with sickle cell disease. The American Journal of Clinical Nutrition76(1): 218–225.
6.
BardenEMZemelBSKawchakDA. (2000) Total and resting energy expenditure in children with sickle cell disease. Journal of Pediatrics136(1): 73–79.
7.
BeeryKEBeeryNA (2004) The Beery- Buktenica Developmental Test of Visual-Motor Integration (5th edn). Minneapolis, MN: NCS Pearson.
8.
BennettEL (2011) Understanding growth failure in children with homozygous sickle-cell disease. Journal of Pediatric Oncology Nursing28(2): 67–74.
9.
CaseR (1985) Intellectual Development: A Systematic Reinterpretation. New York: Academic Press.
ChapmanCDWardSDMcColleySA. (2002) Clinical practice guideline: Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics109(4): 704–712.
12.
ChawlaASprinzPGWelchJ. (2013) Weight status of children with sickle cell disease. Pediatrics131(4): e1168–e1173.
13.
CheongJLHuntRWAndersonPJ. (2008) Head growth in preterm infants: Correlation with magnetic resonance imaging and neurodevelopmental outcome. Pediatrics121(6): e1534–e1540.
14.
DekkerLHFijnvandraatKBrabinBJ. (2012) Micronutrients and sickle cell disease, effects on growth, infection and vaso-occlusive crisis: A systematic review. Pediatric Blood & Cancer59(2): 211–215.
15.
Fattal-ValevskiAToledano-AlhadefHLeitnerY. (2009) Growth patterns in children with intrauterine growth retardation and their correlation to neurocognitive development. Journal of Child Neurology24(7): 846–851.
16.
FernaldLCNeufeldLMBartonLR. (2006) Parallel deficits in linear growth and mental development in low-income Mexican infants in the second year of life. Public Health Nutrition9(2): 178–186.
17.
GoldJIJohnsonCBTreadwellMJ. (2008) Detection and assessment of stroke in patients with sickle cell disease: Neuropsychological functioning and magnetic resonance imaging. Pediatric Hematology and Oncology25(5): 409–421.
18.
GoldsteinNAKellerRReyK. (2011) Sleep-disordered breathing and transcranial Dopplers in sickle cell disease. Archives of Otolaryngology Head and Neck Surgery137(12): 1263–1268.
19.
HankinsJSWareRERogersZR. (2005) Long-term hydroxyurea therapy for infants with sickle cell anemia: The HUSOFT extension study. Blood106(7): 2269–2275.
20.
HeinonenKRaikkonenKPesonenAK. (2008) Prenatal and postnatal growth and cognitive abilities at 56 months of age: A longitudinal study of infants born at term. Pediatrics121(5): e1325–e1333.
21.
HendersonRASaavedraJMDoverGJ (1994) Prevalence of impaired growth in children with homozygous sickle cell anemia. The American Journal of the Medical Sciences307(6): 405–407.
22.
KaufmanAKaufmanN (1983) KABC—Kaufman Assessment Battery for Children: Administration and Scoring Manual. Circle Pines, MN: American Guidance Service.
23.
KnightSSinghalAThomasP. (1995) Factors associated with lowered intelligence in homozygous sickle cell disease. Archives of Disease in Childhood73(4): 316–320.
24.
McClellanCBSchatzJSanchezC. (2008) Validity of the Pediatric Quality Of Life Inventory for youth with sickle cell disease. Journal of Pediatric Psychology33(10): 1153–1162.
25.
McGrewKWoodcockRW (2001) Woodcock-Johnson III Technical Manual. Itasca, IL: Riverside Publishing.
26.
MitchellMJCarpenterGJCrosbyLE. (2009) Growth status in children and adolescents with sickle cell disease. Pediatric Hematology and Oncology26(4): 202–215.
27.
NaborsNAFreymuthAK (2002) Attention deficits in children with sickle cell disease. Perceptual and Motor Skills95(1): 57–67.
28.
NagyZWesterbergHSkareS. (2003) Preterm children have disturbances of white matter at 11 years of age as shown by diffusion tensor imaging. Pediatric Research54(5): 672–679.
29.
NewcomerPLHammilDD (1997) Examiner’s Manual. Test of Language Development Primary: Third Edition. Austin, TX: Pro-Ed.
30.
NobleKGNormanMFFarahMJ (2005) Neurocognitive correlates of socioeconomic status in kindergarten children. Developmental Science8(1): 74–87.
31.
PegelowCHMacklinEAMoserFG. (2002) Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood99(8): 3014–3018.
32.
PietzJPeterJGrafR. (2004) Physical growth and neurodevelopmental outcome of nonhandicapped low-risk children born preterm. Early Human Development79(2): 131–143.
33.
PufferESSchatzJCRobertsCW (2010) Relationships between somatic growth and cognitive functioning in young children with sickle cell disease. Journal of Pediatric Psychology35(8): 892–904.
34.
ReaganPBSalsberryPJ (2005) Race and ethnic differences in determinants of preterm birth in the USA: Broadening the social context. Social Science & Medicine60(10): 2217–2228.
RhodesMAkohoueSAShankarSM. (2009) Growth patterns in children with sickle cell anemia during puberty. Pediatric Blood & Cancer53(4): 635–641.
37.
SandersKALabottSMMolokieR. (2010) Pain, coping and health care utilization in younger and older adults with sickle cell disease. Journal of Health Psychology15: 131–137.
38.
SchatzJ (2004) Brief report: Academic attainment in children with sickle cell disease. Journal of Pediatric Psychology29(8): 627–633.
39.
SchatzJPufferES (2006) Neuropsychological aspects of sickle cell disease. In: BrownRT (ed.) Comprehensive Handbook of Childhood Cancer and Sickle Cell Disease: A Biopsychosocial Approach. Oxford; New York: Oxford University Press, pp. 449–470.
40.
SchatzJRobertsCW (2007) Neurobehavioral impact of sickle cell disease in early childhood. Journal of the International Neuropsychological Society13(6): 933–943.
41.
SchatzJFinkeRRobertsCW (2004) Interactions of biomedical and environmental risk factors for cognitive development: A preliminary study of sickle cell disease. Journal of Developmental & Behavioral Pediatrics25(5): 303–310.
42.
SchatzJFinkeRLKellettJM. (2002) Cognitive functioning in children with sickle cell disease: A meta-analysis. Journal of Pediatric Psychology27(8): 739–748.
43.
SchatzJPufferESSanchezC. (2009) Language processing deficits in sickle cell disease in young school-age children. Developmental Neuropsychology34(1): 122–136.
44.
ScheepensAModerscheimTAGluckmanPD (2005) The role of growth hormone in neural development. Hormone Research64(Suppl. 3): 66–72.
45.
SinghalAParkerSLinsellL. (2002) Energy intake and resting metabolic rate in preschool Jamaican children with homozygous sickle cell disease. The American Journal of Clinical Nutrition75(6): 1093–1097.
46.
SmedlerACFaxeliusGBremmeK. (1992) Psychological development in children born with very low birth weight after severe intrauterine growth retardation: A 10-year follow-up study. Acta Paediatrica81(3): 197–203.
47.
SolimanATel BannaNalSalmiI. (1997) Growth hormone secretion and circulating insulin-like growth factor-I (IGF-I) and IGF binding protein-3 concentrations in children with sickle cell disease. Metabolism46(11): 1241–1245.
48.
SteenRGXiongXMulhernRK. (1999) Subtle brain abnormalities in children with sickle cell disease: Relationship to blood hematocrit. Annals of Neurology45(3): 279–286.
49.
SteinbergMH (2008) Sickle cell anemia, the first molecular disease: Overview of molecular etiology, pathophysiology, and therapeutic approaches. The Scientific World Journal8: 1295–1324.
50.
StevensMCMaudeGHCupidoreL. (1986) Prepubertal growth and skeletal maturation in children with sickle cell disease. Pediatrics78(1): 124–132.
51.
ThomasPWSinghalAHemmings-KellyM. (2000) Height and weight reference curves for homozygous sickle cell disease. Archives of Disease in Childhood82(3): 204–208.
52.
WangWCEnosLGallagherD. (2001) Neuropsychologic performance in school-aged children with sickle cell disease: A report from the Cooperative Study of Sickle Cell Disease. Journal of Pediatrics139(3): 391–397.
53.
WangWCMoralesKHScherCD. (2005) Effect of long-term transfusion on growth in children with sickle cell anemia: Results of the STOP trial. Journal of Pediatrics147(2): 244–247.
54.
WhiteDASalorioCFSchatzJ. (2000) Preliminary study of working memory in children with stroke related to sickle cell disease. Journal of Clinical and Experimental Neuropsychology22(2): 257–264.
55.
ZemelBSKawchakDAOhene-FrempongK. (2007) Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease. Pediatric Research61(5 Pt. 1): 607–613.
